Top

International Urology and Nephrology

Published in:

14-05-2023 | Sarcopenia | Nephrology - Letter to the Editor

Reply to comment on “Hyperuricemia may be associated with muscle wellness in older adults”

Authors: Fatma Sena Dost, Ahmet Turan Isik

Published in: International Urology and Nephrology | Issue 1/2024

Excerpt

Editor, …

Oncel Yoruk E, Dost FS, Ontan MS et al (2023) Hyperuricemia may be associated with muscle wellness in older adults. Int Urol Nephrol. https://doi.org/10.1007/s11255-023-03588-zCrossRefPubMed

https://www.escardio.org/Education/ESC-Prevention-of-CVD-Programme/Risk-assessment/esc-cvd-risk-calculation-app

Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169CrossRef

Stanaway FF, Gnjidic D, Blyth FM et al (2011) How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over. BMJ 343:d7679. https://doi.org/10.1136/bmj.d7679CrossRefPubMedPubMedCentral

Dost FS, AtesBulut E, Dokuzlar O et al (2022) Sarcopenia is as common in older patients with dementia with Lewy bodies as it is in those with Alzheimer’s disease. Geriatr Gerontol Int 22(5):418–424. https://doi.org/10.1111/ggi.14383CrossRefPubMed

Title: Reply to comment on “Hyperuricemia may be associated with muscle wellness in older adults”
Authors: Fatma Sena Dost
Ahmet Turan Isik
Publication date: 14-05-2023
Publisher: Springer Netherlands
Keyword: Sarcopenia
Published in: International Urology and Nephrology / Issue 1/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-023-03634-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Knowledge landscapes and emerging trends of cardiorenal syndrome type 4: a bibliometrics and visual analysis from 2004 to 2022

Choosing the larger kidney on CT volumetry: a study on the early post-donation kidney function of living donors

Interference in the nutrient-sensing and inflammatory signaling pathways by renal autophagy activation in mice with late stage diabetic nephropathy

Knowledge mapping of UMOD of English published work from 1985 to 2022: a bibliometric analysis

Effects of low-intensity extracorporeal shock wave therapy on lipopolysaccharide cystitis in a rat model of interstitial cystitis/bladder pain syndrome

Prediction of acute kidney injury in patients with liver cirrhosis using machine learning models: evidence from the MIMIC-III and MIMIC-IV

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials